S-Evans Biosciences

Cell therapy

Privately held: no public share price · China

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
0Diseases
Showing 1 of 1 assets
Target & Modality
Phase 1/2
Mesenchymal stem cell / Tissue regenerationCell therapy
Indication not yet linked

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.